12/5/2019Amgen's IND for Osteoporosis Drug Romosozumab Approved in China

12/5/2019XiAn Janssen's Application for 2nd Indication of Erleada Accepted in C...

12/5/2019AstraZeneca-Merck Lynparza Approved in China for Ovarian Cancer

12/4/2019Bio-Thera's IND for Biosimilar of Stelara (Ustekinumab) Approved in Ch...

12/4/2019Additional Indication for Lenvima (Lenvatinib) For Differentiated Thyr...

12/3/2019Why Chinese Biotech Companies Are Not For Faint-Hearted Investors

12/3/2019New Round of Negotiation for NRDL Access Begins as Big Pharma Bosses L...

12/3/2019Biotech Startup Alphamab to Raise $230M in HK IPO

12/3/2019GI Innovation Out-licenses Immunotherapy Drug Candidate to Simcere Pha...

12/2/2019State Council Issues New Centralized Drug Procurement Purchase and Use...

12/2/2019NMPA Announces Withdrawal of Additional 68 Certificate Requirements to...

11/29/2019Recent Executive Moves

11/29/2019NMPA Approves Chipscreen's Chidamide (Epidaza) for Breast Cancer

11/29/2019Hanmi's Chinese Partner to Start Trials for Anticancer Treatment

11/29/2019Amgen Striding Ahead in Innovative Medical Solutions

11/29/2019Global Drugmakers Strike Deal to Slash Prices in China

11/29/2019WuXi ATU and GeneMedicine Sign Agreement for Oncolytic Virus Products

11/29/2019Financial-related Company News in Brief

11/29/2019NMPA Issues Implementation Plan for Reform Measures in Free Trade Pilo...

11/28/2019NH Reports Latest Data on Chinese Smoking Cessation Market

11/28/2019Expanding into Asia-Pacific: Life Sciences Opportunities and Strategie...

11/27/2019China Opens Food & Drug Center of Excellence with Help of UNIDO

11/27/2019State Council to Issue New Healthcare Reform Policy Relating to Centra...

11/27/2019China Builds Service Network for Child Health

11/26/2019MSD Gets Third Chinese Approval for Keytruda in First-line NSCLC

11/26/2019Pharma Industry Performance Continued to Rise, Albeit Slower Rates in ...

11/26/2019NHDRC and Amgen Partner on Three-Year Program to Study Impacts of Agin...

11/26/2019What Does Chinese Biotech Want from Professional Investors?

11/26/2019China Approves Astellas's XTANDI for Treatment of Adult Men with Metas...

11/26/2019Chi-Med's Surufatinib Granted Orphan Drug Designation by the USFDA

Page:127/357 Total number of articles:10690: [First][<<] [125] [126] [127] [128] [129] [>>] [End]